Ototoxicity following Vinblastine chemotherapy in a patient of Hodgkin's Lymphoma
In Indian Journal of Otology
By: Nirban RK.
Contributor(s): kapoorakhil1987@gmail.com | Maharia S | Narayan S | Kapoor A.
Material type:
Item type | Current location | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|
![]() |
Tata Memorial Hospital | Available | AR17251 |
Sudden hearing loss is a well-known complication of certain chemotherapeutic agents. However, vinblastine has seldom been implicated causing ototoxicity. We report a case of sudden bilateral hearing loss in a 36-year-old male patient of Mixed cellularity Hodgkin's lymphoma following standard adriamycin, bleomycin, vinblastine, and dacarbazine chemotherapy.
There are no comments for this item.